Reformulation. Dyax shall remain responsible for any activities relating to the reformulation of the Product, including those that are conducted in connection with the EMA approved Pediatric Investigational Plan.
Appears in 2 contracts
Sources: Joint Development and License Agreement (Dyax Corp), Joint Development and License Agreement (Dyax Corp)